Literature DB >> 2276384

Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

M Linnoila1, J M Stapleton, R Lister, H Moss, E Lane, A Granger, M J Eckardt.   

Abstract

Effects of alprazolam, alone and in combination with ethanol, on psychomotor and cognitive performance were studied in healthy male volunteers and compared to effects of diazepam. Alprazolam 2 mg produced relatively long-lasting impairments on tests of tracking, verbal and nonverbal information processing, and memory, and decreased blood pressure without a change in heart rate or plasma norepinephrine levels. Although ethanol consumption was demonstrated to produce additive decrements in performance on certain tasks, there was little evidence to support a synergistic effect. Alprazolam 2 mg was accompanied by increased self-reports of side effects, especially drowsiness. Low dose alprazolam, diazepam, and ethanol produced significantly fewer side effects than 2 mg alprazolam, but significantly more than placebo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276384     DOI: 10.1007/bf02657051

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  52 in total

1.  Diazepam actions and plasma concentrations following ethanol ingestion.

Authors:  S M MacLeod; H G Giles; G Patzalek; J J Thiessen; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

2.  Second-generation antidepressants.

Authors:  L E Hollister
Journal:  Ration Drug Ther       Date:  1982-12

3.  Suppression of norepinephrine appearance rate in plasma by diazepam in humans.

Authors:  P P Roy-Byrne; N Lewis; E Villacres; D J Greenblatt; R I Shader; R C Veith
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  Alprazolam-induced manic reaction.

Authors:  R D France; K R Krishnan
Journal:  Am J Psychiatry       Date:  1984-09       Impact factor: 18.112

5.  Benzodiazepines in depressive disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Arch Gen Psychiatry       Date:  1978-11

Review 6.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

7.  Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.

Authors:  D J Greenblatt; J S Harmatz; C Dorsey; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1988-09       Impact factor: 6.875

8.  Effects of antidepressants on skilled performance.

Authors:  M Linnoila; J Johnson; K Dubyoski; M S Buchsbaum; M Schneinin; C Kilts
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.

Authors:  I S Kolin; O I Linet
Journal:  J Clin Psychiatry       Date:  1981-04       Impact factor: 4.384

10.  Alprazolam-induced mania: two clinical cases.

Authors:  G W Arana; C Pearlman; R I Shader
Journal:  Am J Psychiatry       Date:  1985-03       Impact factor: 18.112

View more
  12 in total

Review 1.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

2.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

3.  Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats.

Authors:  Ajaykumar N Sharma; Ashish Pise; Jay N Sharma; Praveen Shukla
Journal:  Metab Brain Dis       Date:  2014-08-17       Impact factor: 3.584

Review 4.  Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation.

Authors:  S D Ferrara; S Zancaner; R Giorgetti
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

5.  The additive effects of alcohol and benzodiazepines on driving.

Authors:  Hillary G Maxwell; Sacha Dubois; Bruce Weaver; Michel Bédard
Journal:  Can J Public Health       Date:  2010 Sep-Oct

Review 6.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

Review 7.  Biomarkers for the effects of benzodiazepines in healthy volunteers.

Authors:  S J de Visser; J P van der Post; P P de Waal; F Cornet; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

8.  Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers.

Authors:  Jørgen G Bramness; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-09-20       Impact factor: 2.953

Review 9.  The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam.

Authors:  G W Kunsman; J E Manno; B R Manno; C M Kunsman; M A Przekop
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of alprazolam. Therapeutic implications.

Authors:  D J Greenblatt; C E Wright
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.